Bionano Genomics, Inc.
-
Ticker
BNGO
-
Industry
Diagnostic Substances More
-
Sector
Healthcare More
- 201-500 Employees
- Based in San Diego, California
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano’s Saphyr system is a platform for ultra-sensitive and ultra-specific
…More structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools, and genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns.
Bionano Genomics, Inc.
Most Recent Responsibility Report
MOST RECENT
2023 Corporate Responsibility Overview
Report Locked. Bionano Genomics, Inc. has reached its limit for free report views.
Our service enables potential investors to review the most recent and archived Bionano Genomics, Inc. Sustainability Report, Bionano Genomics, Inc. Corporate Social Responsibility Report, Bionano Genomics, Inc. CSR Report, Bionano Genomics, Inc. Corporate Responsibility, Bionano Genomics, Inc. CR Report, Bionano Genomics, Inc. Citizenship Report, Bionano Genomics, Inc. ESG Report, and Bionano Genomics, Inc. Environmental Report online.